Research

RSRT Collaborates with ProQR to Bring RNA Editing to the Clinic

Record 2023 Awards Will Advance Cures

A Concise Summary of Gene Therapy Clinical Trials for Rett Syndrome

First Pediatric Patient Dosed in Taysha US Clinical Trial

Taysha Pediatric Gene Therapy Trial Is Open for Enrollment in US

Neurogene Doses First Two Patients in Pediatric US Trial

Taysha Expands Age Eligibility for Canadian Clinical Trial

Taysha Provides Update on Patient #1 and #2

Webinar: Launch of the Rett Syndrome Global Registry

Taysha Doses Patient #2 and Provides Additional Updates

Taysha Reports on Patient #1

RSRT Doubles Down on RNA Editing for Rett Syndrome with Additional Funding to Beal Lab at UC Davis

Taysha Cleared to Dose Second Patient in Gene Therapy Trial

Understanding Rett through the Power of Artificial Intelligence

Neurogene Merges with Neoleukin

Lutz and Liu Dream Team Awarded $23 Million to Cure Four Rare Diseases: Rett is One of Them

Details on Neurogene Gene Therapy Trial Now on ClinicalTrial.gov

Taysha Gene Therapies Doses First Rett Syndrome Patient